Home • Projects • Gaboxadol - Investigational Agent

Gaboxadol is a direct-acting GABAA agonist under development by Danish pharmaceutical company Lundbeck for the treatment of sleep disorders.

		Next»

---

Home | New On This Site | Products & Services | Company A-Z | Industry Projects | White Papers | Jobs & Careers | Press Releases | Events & Exhibitions | Newsletter | Organisations | About Us | Contact Us | Advertise With Us |